Lowes Reports Quarterly Earnings Revenue Surges but Profit Declines Amid Cost Pressures Equities Close Higher as Technology and Healthcare Lead SP 500 Adds 062 Average US Household Savings for Those in Their 50s A Reality Check IBM Gains 27 Billion in Market Cap After US Quantum Computing Investment Announcement B Riley Raises Price Target on Silicon Motion Signaling Optimism DeepSeek AI Claims Affordable HighPerformance Model Training Without Advanced Chips Conduent CNDT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise OVLY Q3 2023 Earnings Steady EPS of 089 Reported Flat Stock Reaction APLD Q1 2026 Earnings Significant EPS Miss Sends Stock Down 45 Viking Holdings VIK Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue Starwood Property Trust STWD Q1 2026 Earnings EPS Miss Amid Stable Market Performance Nauticus Robotics KITT Faces Renewed Selling Pressure as Price Tests Support Melco Resorts Entertainment MLCO Edges Lower Amid Cautious Trading Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted Moelis Company MC Holds Steady Near Support as Volume Remains Modest Quanta Services PWR Faces Minor Pullback Maintains Position Above Crucial Support Milburn Criticizes Welfare Spending More on Benefits Than Jobs for Youth KO Q1 2026 Earnings EPS Beats Estimates by 29 Stock Slips on Revenue Concerns Vine Hill Capital Investment Corp II VHCP Stays Near Trust Value as SPAC Market Waits for Catalyst Seer Inc SEER Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline RPAY Q1 2026 Earnings Earnings Per Share Surpasses Expectations CDNA Q1 2026 Earnings Major EPS Beat Signals StrongerThanExpected Profitability CTBI Q1 2026 Earnings Solid Earnings Beat Amid Stable Regional Banking Operations FGNX Q1 2026 Earnings Massive EPS Surprise of 2482 Highlights NonOperational Gains REX Q3 2001 Earnings EPS Beats Estimates by 23 as Company Delivers Strong Quarter KURA Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Development Intensifies